Halozyme Therapeutics Market Cap

Halozyme Therapeutics has a market cap or net worth of 147.11 billion as of August 15, 2025. Its market cap has increased by 12.38% in one year.

Market Cap

147.11B

Enterprise Value

165.61B

Revenue

22.23B

Ranking

n/a

PE Ratio

14.00

Stock Price

1,121.86

Market Cap Chart

Since May 14, 2004, Halozyme Therapeutics's market cap has increased from 1.94B to 147.11B, an increase of 7,471.01%. That is a compound annual growth rate of 22.56%.

Market Cap History

Date	Market Cap	% Change
Aug 15, 2025	147.11B	16.06%
Dec 31, 2024	126.75B	53.56%
Dec 29, 2023	82.54B	-45.00%
Dec 30, 2022	150.07B	29.37%
Dec 31, 2021	116.00B	1.13%
Dec 31, 2020	114.71B	134.71%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Wal-Mart de México	971.86B
Grupo Financiero Banorte	468.95B
Arca Continental	331.25B
Industrias Peñoles	218.37B
GMéxico Transportes	140.67B
FIBRA Prologis	113.92B
Promotora y Operadora de Infraestructura, S. A. B. de C. V.	101.18B
Fibra UNO	97.38B

Market Cap Rankings